Lifecore Biomedical (NASDAQ: LFCR) reported Q2 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $36.44 million versus the consensus estimate of $35.36 million.

For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.